GlassScriptPhysician profile
Keeva Thurmond
NPI 1417514993
$5,768.04
in general payments reported to CMS, 2019-2025
33 companies · $924 in 2025
The $924 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $377 · 2022: $1,010 · 2023: $1,900 · 2024: $1,556 · 2025: $924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,380.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $972.56 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $926.35 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $535.27 | 2022-2025 | |
| Novo Nordisk INC | $476.04 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $463.59 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $305.09 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $275.19 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $249.29 | 2022-2024 | |
| Amgen INC. | $243.99 | 2021-2025 | Evenity, Prolia, Otezla |
| Dexcom, INC. | $161.15 | 2021-2025 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $139.63 | 2021-2024 | Nexletol |
| Glaxosmithkline, LLC. | $130.50 | 2021-2024 | Trelegy Ellipta |
| Exact Sciences Corporation | $90.30 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $77.79 | 2021-2024 | Verquvo, Gardasil, Capvaxive |
| Eisai INC. | $74.03 | 2021-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $73.96 | 2023-2024 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $70.24 | 2022 | |
| Boston Scientific Corporation | $67.63 | 2023-2024 | Watchman Flx, Watchman Access System |
| Daiichi Sankyo INC. | $50.39 | 2024-2025 | Injectafer |
| Idorsia Pharmaceuticals US INC | $43.31 | 2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $41.45 | 2023-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $41.02 | 2022 | |
| Amarin Pharma, INC. | $37.88 | 2021 | |
| Supernus Pharmaceuticals, INC. | $37.59 | 2023 | Qelbree |
| Biohaven Pharmaceuticals, INC. | $37.28 | 2021 | |
| Dynavax Technologies Corporation | $22.11 | 2023 | Heplisav-B |
| Tolmar, INC. | $20.70 | 2024 | |
| Lifescan, INC. | $20.42 | 2023 | |
| Astellas Pharma US INC | $19.46 | 2024 | Veozah |
| Tolmar Pharmaceuticals, INC. | $18.51 | 2022 | |
| Smith+Nephew, INC. | $16.49 | 2023 | Regranex, Collagenase Santyl |
| Kowa Pharmaceuticals America, INC. | $14.45 | 2021 | |
| Currax Pharmaceuticals LLC | $14.38 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keeva Thurmond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.